Dr Reddy's Laboratories denies plans to implement a 25% workforce cost reduction.
The pharmaceutical manufacturer deems the news of the plans to reduce workforce costs by 25% to be factually incorrect.
The company clarifies that there is currently no event or information which requires a disclosure.
The potential cost reduction initiative may have been due to underperformance in new ventures, such as the therapeutics division and nutraceuticals sector.